LM11A-31
From Wikipedia, the free encyclopedia
| Clinical data | |
|---|---|
| Other names | LM-11A-31 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H25N3O2 |
| Molar mass | 243.351 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
LM11A-31 is an experimental drug developed for Alzheimer's disease and Huntington's disease.[1][2][3][4][5][6][7][8]